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Humans have approximately 400 intact odorant receptors, but each individual 27 
has a unique set of genetic variations that lead to variation in olfactory perception.  28 
We used a heterologous assay to determine how often genetic polymorphisms in 29 
odorant receptors alter receptor function. We identified agonists for 18 odorant 30 
receptors and found that 63% of the odorant receptors we examined had 31 
polymorphisms that altered in vitro function. On average, two individuals differ 32 
functionally at over 30% of their odorant receptor alleles. To show that these in 33 
vitro results are relevant to olfactory perception, we verified that variations in 34 
OR10G4 genotype explain over 15% of the observed variation in perceived 35 
intensity and over 10% of the observed variation in perceived valence for the high 36 
affinity in vitro agonist guaiacol, but do not explain phenotypic variation for the 37 
lower affinity agonists vanillin and ethyl vanillin.38 
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The human genome contains approximately 800 odorant receptor genes that have been 39 
shown to exhibit high genetic variability1-3.  In addition, humans exhibit considerable 40 
variation in the perception of odorants4, 5 and variation in an odorant receptor predicts 41 
perception in four cases: loss of function in OR11H7P, OR2J3, OR5A1, and OR7D4 42 
leads to elevated detection thresholds for the respective agonists isovaleric acid6, cis-3-43 
hexen-1-ol7, -ionone8, and androstenone9. These results suggest that although the 44 
olfactory system uses a combinatorial code where multiple receptors encode a given 45 
odorant, a single receptor can have a large influence on the perception of an odorant.  46 
Understanding the role of a single receptor requires functional data for 47 
receptor/odorant pairs.  Matching mammalian odorant receptors to ligands has seen 48 
limited success, and the picture is even worse when considering human odorant 49 
receptors; ligands have been published for only 22 of the approximately 400 intact 50 
human odorant receptors6, 8-17. This lack of data is a critical bottleneck in the field; 51 
matching ligands to odorant receptors is essential for understanding the olfactory system 52 
at all levels and is building viable models of olfaction. 53 
Using a high-throughput system for functional testing of odorant receptors18, we can 54 
now elucidate the role of missense single nucleotide polymorphisms in odorant receptor 55 
function. Here we identify ligands for several orphan odorant receptors, determine the 56 
prevalence and functional consequences of missense mutations in odorant receptors, 57 
and measure the effect of these functional changes on human olfactory perception. 58 
Results 59 
High-throughput screening of human odorant receptors 60 
To identify agonists for a variety of odorant receptors, we cloned a library of 511 61 
human odorant receptors for a high-throughput heterologous screen. These clones 62 
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represent 394 (94%) of the 418 intact odorant receptor genes, and 428,793 (47%) of 63 
their 912,912 intact odorant receptor alleles present in the 1000 Genomes Project. Some 64 
odorant receptors were represented by multiple nonsynonymous alleles in the screen.  65 
We screened the odorant receptor library with a panel of 73 odorants that have been 66 
used in previous psychophysical testing9, 19 and used a cyclic adenosine 67 
monophosphate (cAMP)-mediated luciferase assay to measure receptor activity20 68 
(Supplementary Fig. 1). In the primary screen we stimulated at a concentration of 100 69 
µM. We selected 1572 odorant/receptor pairs from this primary screen for a secondary 70 
screen in which each odorant receptor was tested against a no-odor control as well as 1, 71 
10 and 100 µM concentrations of the odorant in triplicate. For 425 odorant/receptor 72 
pairs, at least one concentration of the odorant produced significantly higher activation 73 
than the no-odor control. These odorant/receptor pairs included 190 clones representing 74 
160 unique odorant receptors.  75 
We then constructed dose-response curves for at least one putative agonist of 160 76 
odorant receptors. 27 odorant receptors showed a significant response to at least one 77 
agonist, including nine that have previously been shown to respond to at least one 78 
agonist in the published literature9, 16, 17 (Fig. 1). For the other 18 odorant receptors we 79 
identified new agonists. This nearly doubles the total number of published human 80 
odorant receptors with known agonists, bringing the total to 406, 8-17. The receptors 81 
identified by this method are spread throughout 9 of the 13 gene families of odorant 82 
receptors21 (Fig. 2), suggesting that our assay is useful for examining ligand-receptor 83 
interactions across a wide variety of odorant receptors.  84 
Genetic variation in odorant receptors 85 
We identified agonists for seven odorant receptors that segregate between intact and 86 
disrupted forms (Table 1), bringing the total number of segregating pseudogenes with 87 
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known agonists to eight6. Combined with psychophysics in a genotyped population, 88 
these odorant receptor-agonist pairs can be used to probe the role of a single odorant 89 
receptor in olfactory perception. 90 
In addition to segregating pseudogenes and missense variation in conserved amino 91 
acid residues, a segregating missense variation that alters non-conserved amino acid 92 
residues of odorant receptors can also account for a portion of the variance in odor 93 
perception7-9. How many of the odorant receptors with intact open reading frames have 94 
functionally different variants, adding to the already considerable amount of variation in 95 
the human odorant receptor repertoire? We found a median of 5 alleles with a minor 96 
allele frequency (MAF) greater than 1% across 418 odorant receptors in the 1000 97 
Genomes Project. 18 odorant receptors had only one allele with an MAF over 1% across 98 
the 2184 haplotypes. In contrast, OR51A2 had 19 different variants with an MAF over 99 
1%. The odorant receptors for which we identified agonists did not exhibit a significantly 100 
different number of polymorphisms than odorant receptors without identified agonists 101 
(median alleles = 5 for both sets, Mann-Whitney U-test, Z = 0.77, p = 0.44, 2-sided). 102 
To test how variability in amino acid sequence affected odorant receptor activation 103 
by odorants, we targeted odorant receptors with at least one known agonist and cloned 104 
alleles from pooled genomic DNA with the goal of representing the majority of protein-105 
coding alleles seen in the 1000 Genomes Project. For 16 odorant receptors we 106 
successfully cloned 51 alleles, representing an average of 27,118 (77%) of their 34,944 107 
alleles present in the 1000 Genomes Project. One mechanism through which genetic 108 
polymorphisms could influence receptor function is by altering cell-surface expression. 109 
We assessed the cell surface expression of these 51 cloned alleles using live-cell 110 
immunostaining against the N-terminal Rho tag followed by Fluorescent Activated Cell 111 
Sorting (FACS).  Relative surface expression among each set of variants does not 112 
correlate with either relative potency (Spearman rho=0.04, p=0.82, Supplementary Fig. 113 
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2a) or relative efficacy (Spearman rho=0.13, p=0.45, Supplementary Fig. 2b) of the 114 
variants in the functional assay.  While a complete lack of surface expression eliminates 115 
receptor responses to known agonists, a high level of surface expression does not 116 
reliably confer additional sensitivity.  A small amount of cell surface expression is 117 
sufficient to confer functional responses.  In summary, FACS does not provide enough 118 
resolution to determine if functional variation is due to cell-surface expression defects. 119 
Functional consequences of genetic variation 120 
We screened 46 of the alleles used in the FACS analysis against 55 odorants 121 
chosen quantitatively to span the physicochemical space17 (Supplementary Fig. 3). 122 
Across odorants the absolute magnitudes of response varied, but the relative responses 123 
of variant alleles remained consistent (Fig. 3a,b, Supplementary Fig. 4). In other words, 124 
if a variant is hypersensitive to one agonist, that variant tends to be hypersensitive to all 125 
agonists. We found no case of a genetic change that resulted in a change in odor tuning 126 
(Supplementary Fig. 4), but our odorant library design was chosen to span odorant 127 
space and was therefore not ideal for identifying more subtle changes. 128 
We then examined how the variant allele responses compared across a range of 129 
concentrations by constructing a dose response curve from 10 nM to 10 mM (Fig. 3c, 130 
Supplementary Fig. 5).  Here, we included the 15 odorant receptors tested against all 55 131 
odorants as well as 12 additional odorant receptors. We typically used only a single 132 
agonist, as our results from using a broad set of odorants suggested that the differences 133 
between alleles using one odorant were highly correlated to differences between alleles 134 
using different odorants. We fit the data to a sigmoid curve and compared the variant 135 
alleles using an extra sums-of-squares test. A pair of alleles was classified as 136 
hyper/hypofunctional if one allele in the pair had both a lower potency (EC50) and a 137 
lower efficacy (maximum value). Comparing one allele to all other alleles of the same 138 
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odorant receptor from the 1000 Genomes Project revealed that 11% of the alleles were 139 
hyperfunctional, 68% were indistinguishable and 6.8% were hypofunctional.  7.9% of the 140 
alleles were pseudogenes and for 5.5% of the alleles potency and efficacy did not 141 
change concordantly, so we could not clearly classify them as hypo or hyperfunctional 142 
(Fig. 4a). 63% (17/27) of the odorant receptors we examined had polymorphisms that 143 
altered in vitro function.  Residues that are polymorphic across alleles with measured 144 
function are shown in Figure 4b.  There is no obvious pattern to the amino acids that 145 
change function; they are found all over the protein. The odds that a residue altered 146 
function in our assay did not correlate with evolutionary conservation (GERP score, r = –147 
0.04, p = 0.83), predictions from SIFT (r = 0.05, p = 0.80), or predictions from PolyPhen 148 
(r = –0.05, p = 0.81). 149 
To quantify functional differences across the 1000 Genomes Project population we 150 
assigned in vitro results to each participant according to their allele type.  We had in vitro 151 
results for 46,561 (79%) of the 58,968 alleles (27 odorant receptors x 1092 subjects x 2 152 
alleles). When we conservatively classified all pairwise comparisons including those 153 
involving untested alleles as functionally identical, we saw an average of 16 functional 154 
differences in dose response out of 54 possible functional differences (27 odorant 155 
receptors tested in dose-response x 2 alleles, Fig. 5a, histogram). When we classified all 156 
pairwise comparisons including an untested allele as functionally different, we saw an 157 
average of 22 functional differences in dose response out of 54 possible functional 158 
differences.  These results were consistent if we excluded the 500 related participants.  159 
In other words, two individuals differ functionally at over 30% (16/54) of their odorant 160 
receptor alleles.  Pairs where both participants had Asian ancestry (CHB, CHS, and 161 
JPT) were more functionally similar than pairs where neither participant had Asian 162 
ancestry (median Asian = 13; median non-Asian = 17; Mann-Whitney U-test, z=127, p < 163 
0.0001, 2-sided).  Pairs where both participants had African ancestry (ASW, LWK, and 164 
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YRI) were more functionally different than pairs where neither participant had African 165 
ancestry (median African = 16; median non-African = 15; Mann-Whitney U-test, z=29 p < 166 
0.0001, 2-sided)22, in line with those populations having a greater genetic diversity (Fig. 167 
5b).  However, when taking genetic diversity into account, pairs where both participants 168 
had African ancestry (ASW, LWK, and YRI) were more functionally similar than pairs 169 
where neither participant had African ancestry (median African = –0.83; median non-170 
African = 0.36; Mann-Whitney U-test, z=149, p < 0.0001, 2-sided) (Fig. 5c).  This shows 171 
that, although there is greater genetic variability among Africans, much of this diversity 172 
does not translate into functional differences relative to other groups. 173 
Perceptual consequences of genetic variation 174 
We have so far shown that genetic changes are widespread in the human population 175 
and that these genetic changes result in widespread in vitro functional changes. We next 176 
set out to determine if the observed in vitro functional changes lead to the predicted 177 
perceptual consequences.  We selected an odorant receptor, OR10G4, for further 178 
testing because we had genomic DNA of subjects that had been tested for their 179 
perception of three OR10G4 agonists19, and because functional and non-functional 180 
OR10G4 alleles were common in the 1000 Genomes Project22. We successfully 181 
obtained OR10G4 sequences from 308 of the 391 participants who had rated their 182 
perceived intensity and valence for guaiacol, vanillin, and ethyl vanillin.  We then 183 
examined the effect of each OR10G4 allele on the perceptual phenotypes (Fig. 6).  184 
There were four OR10G4 alleles with an MAF greater than 4% in the participant 185 
population: the reference allele (ALTYMGPVRK), and three variant alleles that differ 186 
from the reference allele by two (APTYMGPERK), five (VLTYVGPEGQ), or eight 187 
(ALICVSSEGQ) amino acids.  The APTYMGPERK allele was more sensitive to guaiacol 188 
than the reference allele, but the effect was small (log EC50 ALTYMGPVRK = –7.4, log 189 
  9 
EC50 APTYMGPERK = –7.7, sum of squares test, F(3,42) = 6.38, p < 0.002). The 190 
VLTYVGPEGQ allele had a much lower affinity to the three odorants than the reference 191 
allele, but still showed significant responses (log EC50 = –5.5, sum of squares test 192 
against reference, F(3,42) = 459, p < 0.001; sum of squares test against vector control, 193 
F(3,42) = 149, p < 0.001). The ALICVSSEGQ allele was not significantly different from 194 
the control cells transfected with vector only (sum of squares test against vector control, 195 
F(3,42) = 2.2, p = 0.11) (Fig. 6a).  We generated odorant receptors with each of the 196 
SNPs in a reference background and found that no single SNP accounted for the 197 
functional impairment in the VLTYVGPEGQ and ALICVSSEGQ alleles, suggesting that 198 
multiple residues interact to cause the decrease in affinity (Supplementary Fig. 6). 199 
Multiple regression analysis was used to test if OR10G4 allele-type significantly 200 
predicted participants’ perception of the three in vitro agonists.  The predictors, allele 201 
counts (0,1,or 2) for the four alleles with MAF > 4% in the participant population, were 202 
regressed against the odor rating rank.  OR10G4 allele type predicted 15.4% of the 203 
variance in perceived intensity of guaiacol (r2 = 0.165, adjusted r2 = 0.154, compared to 204 
constant model, F(4,303) = 15.0, p < 0.001 after false discovery rate (FDR) correction). 205 
The model estimated that subjects with none of the major alleles would rank the intensity 206 
of guaiacol 24th relative to the other tested odors.  Each copy of the ALTYMGPVRK 207 
allele is associated with an increase in perceived intensity (decreased rank) of guaiacol 208 
by 2.1 ranks ( = 2.10, p < 0.04), and each copy of the VLTYVGPEGQ and 209 
ALICVSSEGQ alleles is associated with a decrease in perceived intensity by 2.4 and 4.3 210 
ranks respectively ( = –2.39, p < 0.02;  = –4.34, p < 0.005).  The APTYMGPERK allele 211 
was not significantly associated with the intensity rank ( = 1.01, p = 0.32).  212 
In addition to intensity, OR10G4 allele type predicted 10.3% of the variance in 213 
perceived valence of guaiacol (r2 = 0.115, adjusted r2 = 0.103, compared to constant 214 
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model, F(4,303) = 9.85, p < 0.001 after false discovery rate (FDR) correction). The 215 
model estimated that subjects with none of the major alleles would rank the valence of 216 
guaiacol 29th relative to the other tested odors. Each copy of the VLTYVGPEGQ and 217 
ALICVSSEGQ alleles is associated with an increase in perceived valence (increased 218 
rank) of guaiacol by 3.3 and 3.7 ranks respectively ( = 3.33, p < 0.002;  = 3.71, p < 219 
0.03), but the ALTYMGPVRK and APTYMGPERK alleles were not significantly 220 
associated with the valence rank ( = –0.69, p = 0.52;  = 1.88, p = 0.08).   221 
In contrast to guaiacol, neither perceived intensity nor valence of vanillin and ethyl 222 
vanillin were predicted by OR10G4 allele-type (vanillin intensity–compared to constant 223 
model, F(4,303) = 0.95, uncorrected p = 0.44; ethyl vanillin intensity–compared to 224 
constant model, F(4,303) = 0.95, uncorrected p = 0.44; vanillin valence–compared to 225 
constant model, F(4,303) = 0.84, uncorrected p = 0.50; ethyl vanillin valence–compared 226 
to constant model, F(4,303) = 0.50, uncorrected p = 0.74).  As further controls, the 308 227 
participants were also psychophysically tested for their intensity and valence perception 228 
of 63 odors that are not known to be OR10G4 agonists, as well as two solvents.  Of the 229 
68 compounds, only guaiacol intensity and valence were significantly correlated with 230 
OR10G4 allele type (Fig. 6c,d). 231 
Discussion 232 
Here we have identified 27 odorant receptors with known agonists that have 233 
functionally different alleles that segregate in the human population and demonstrated 234 
that this segregation is relevant to human odorant perception. This nearly doubles the 235 
number of human odorant receptors with a known agonist, and is the first investigation of 236 
the functional role of genetic variation in a large set of odorant receptors. Pairing 237 
odorants and odorant receptors and verifying the functional consequences of 238 
segregating polymorphisms in vitro allows us to address previously inaccessible 239 
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questions regarding how activation of an individual odorant receptor alters olfactory 240 
perception. This promises to be a rich future field of study, as we do not currently know 241 
how the odorant receptor array codes for odor threshold, intensity, or character. 242 
Understanding how the functional alteration of an odorant receptor affects the neural 243 
code is a crucial first step in a model of olfactory perception.  244 
Each pair of individuals had, on average, differences in 16-22 out of a possible 54 245 
alleles (27 odorant receptor genes with dose-response data x 2 alleles per subject). If we 246 
extrapolate to the  approximately 400 intact odorant receptors, we would expect each 247 
pair of individuals to differ at somewhere between 237–326 of the 800 alleles.  This 248 
suggests that odor detection at the peripheral level is highly variable. Variation at the 249 
peripheral level leads to variability in odor perception across individuals in several cases; 250 
in addition to the OR10G4/guaiacol association demonstrated here, four olfactory 251 
perceptual phenotypes have previously been linked to a single odorant receptor genes6-9 252 
and five additional olfactory phenotypes have been linked to regions of the genome 253 
containing more than one receptor23-25.  Each individual, therefore, has a highly 254 
personalized set of olfactory receptors that affects his or her perception of odors. 255 
We chose to focus only on SNPs in the coding regions of the odorant receptors due 256 
to the lack of an efficient assay for testing the effects of noncoding polymorphisms on 257 
expression. That said, there is considerable variation in noncoding regions, which can 258 
lead to altered gene transcription26 and even changes in sensory perception27. Similarly, 259 
we did not examine copy number variation, which is widespread in human odorant 260 
receptors28, 29.  Thus, our data underestimate the potential extent of variation in each 261 
individual’s expressed odorant receptor repertoire. 262 
Our study did not find any evidence suggesting SNPs that alter in vitro function are 263 
restricted to a particular domain of the receptor, deviate from neutral evolution, or are 264 
predicted by two popular computational alogrithms.  Note, however, that our study was 265 
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not designed to carefully detect changes due to a particular SNP; because we did not 266 
generate every possible combination of SNPs for the majority of odorant receptors, 267 
SNP-specific alterations may be confounded by linkage in the tested alleles. 268 
Although we found that OR10G4 has at least three in vitro agonists, the OR10G4 269 
allele type only predicted perceived intensity and valence for guaiacol.  The dose-270 
response curves in Figure 6a show that guaiacol is a more potent agonist than either 271 
vanillin or ethyl vanillin.  Although more data is needed, one possible interpretation is 272 
that the intensity and valence of odorants that only weakly activate a receptor will not be 273 
altered by functional variation in the receptor.  Indeed, this is similar to the association 274 
between OR7D4 and androstenone9.  In that case, both of the major alleles respond to 275 
androstenone in vitro, but the WM allele is much less potent than the RT allele.  As with 276 
OR7D4, participants with the lower affinity in vitro allele find the odor to be less intense 277 
and more pleasant. This suggests that not all functional variation in vitro will lead to 278 
perceptual variation, but the exact rules determining how much of this variation is 279 
compensated for at later stages of processing will require further investigation.  280 
OR10G4 explains 15.4% of the variance in guaiacol intensity, which is lower than the 281 
39% of androstenone intensity variation explained by OR7D4 genotype.  The reason for 282 
this lower explanatory value is unclear.  One possibility is that more odorant receptors 283 
play a role in the perception of guaiacol than in the perception of androstenone, 284 
therefore reducing the influence of a single odorant receptor on the percept.  Another is 285 
that confounding variables, such as culture and genetic background may have 286 
differential effects on the two phenotypes.  287 
The role of a single odorant receptor in olfactory perception is currently unknown, in 288 
part because of the large search space for both odorants and odorant receptors and the 289 
redundant nature of the combinatorial code for odorant identity. By assigning ligands to 290 
odorant receptors, measuring the functional consequences of segregating 291 
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polymorphisms in vitro, and linking in vitro function to human behavior, these data 292 
provide a solid platform from which to probe the effects of a single odorant receptor on 293 
olfactory perception. 294 
 295 
 296 
  297 
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Figure Legends 318 
Figure 1: Dose response curves of the most common functional allele for 27 319 
receptors. Circles and solid lines represent the response of the odorant receptor to the 320 
odorant in the title of each pane, X’s and dotted lines represent the response of the 321 
vector-transfected control to the odorant in the title of each pane.  Error bars are 322 
standard error. See Table S1 for odor abbreviations. 323 
 324 
Figure 2: Unrooted tree based on similarity of amino acid properties. 27 odorant 325 
receptors with agonists are highlighted in red, and represent 9 of the 13 odorant receptor 326 
gene families. Grantham’s amino acid property scales were used to quantify receptor 327 
similarity30 and distances were calculated using the unweighted pair group method with 328 
arithmetic mean (UPGMA). 329 
 330 
Figure 3: Functional testing of odorant receptor variants. (a) Sensitivity-ordered 331 
tuning curves for 5 variant alleles of OR2B11 tested against the 55 representative 332 
odorants at 100 µM. If a given odorant did not significantly activate any of the variant 333 
receptors above the no-odor control (2-tailed t-test, =0.05/55), that odorant’s response 334 
was set to zero across all variants. Odorants were ordered along the x-axis according to 335 
the response they elicited from the OR2B11 reference allele (see Fig. S3 for odor 336 
names). Error bars are standard error over three replicates. (b) The responses of the 337 
four variant alleles to the 55 representative odorants at 100 µM are plotted against the 338 
OR2B11 reference allele’s responses. The black line represents the unit slope line. (c) 339 
Dose response curves for the OR2B11 alleles for three different odorants. Y-axis 340 
represents the luciferase value normalized to the reference allele. Error bars are 341 
standard error over three replicates. 342 
 343 
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Figure 4: Summary of functional variation. (a) The type of functional differences 344 
among 27 odorant receptors of 1092 participants from the 1000 Genomes Project. Note 345 
that pseudogenes account for a small portion of the variability relative to missense 346 
variations. (b) Snake plot of a typical odorant receptor showing residues where SNPs 347 
alter the function of the receptor. Amino acid residues that did not vary between any of 348 
the minor alleles and their reference allele are shown in gray. The remaining residues 349 
are colored according to the odds that they alter function given our current dose-350 
response data. Amino acid positions conserved in at least 90% of the receptors are 351 
labeled with their single-letter amino acid code. 352 
 353 
Figure 5: Functional differences between participants. The number of functional 354 
differences (a), nucleotide differences (b), and z-scored functional differences minus z-355 
scored nucleotide differences (c) among 27 odorant receptors of 1092 participants from 356 
the 1000 Genomes Project.  The colors of the squares represent the number of 357 
differences between participants. Participant populations are labeled on the axes and 358 
separated by black grid lines.  The histograms of the number of differences show the 359 
color key used in the main figure. The legend displays ethnic groups from (a-c) at the 360 
place of geographic origin; arrows point to the location of sample collection. ASW, 361 
African ancestry in Southwest USA; CEU, Utah residents with Northern and Western 362 
European ancestry from the CEPH collection; CHB, Han Chinese in Beijing; CHS, Han 363 
Chinese South; CLM, Colombian in Medellin, Colombia; FIN, Finnish; GBR, British 364 
individuals from England and Scotland; IBS, Iberian populations in Spain; JPT, 365 
Japanese in Tokyo; LWK, Luhya in Webuya, Kenya; MXL, Mexican ancestry in Los 366 
Angeles, California; PUR, Puerto Rican; TSI, Tuscanians in Italy; YRI, Yoruba in Ibadan, 367 
Nigeria. 368 
 369 
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Figure 6: OR10G4 allele effects on perceived intensity and valence.  (a) 370 
Concentration response curves of OR10G4 alleles with a frequency greater than 4% in 371 
the participant population.  Error bars are standard errors of 3 replicates. Y-axis values 372 
are normalized to the baseline response of the reference allele. (b) Perceived intensity 373 
and valence rank for three in vitro OR10G4 agonists by allele of OR10G4.   Each 374 
participant is represented twice—once for the maternal and once for the paternal allele. 375 
The width of each violin is proportional to the number of participants assigning a given 376 
rank. The black line inside the violin denotes the median rank. The amino acid changes 377 
are relative to the hg19 reference sequence.  The frequency listed is the allele frequency 378 
in the 308 participants.  All unlisted alleles occurred with a frequency lower than 4%. 379 
Asterisks signify that the allele had a significant effect in the regression model, and are 380 
only shown for regression models that were overall significantly different from a constant 381 
model; one asterisk signifies p < 0.05, two asterisks signify p < 0.01. (c,d) Percentage of 382 
perceptual variance (r2) in intensity (c) and valence (d) ranking explained by OR10G4 383 
allele types. Each odor was analyzed using the multiple linear regression model outlined 384 
in the main text. Three asterisks signifies p < 0.001 after false-discovery rate (FDR) 385 
correction.  For all other odorants, p > 0.05 after FDR correction.  386 
 387 
Table 1: Seven segregating pseudogenes with agonists. The frequency of the 388 
disrupted allele in the 1000 Genomes Project22 is listed. In cases where the variant allele 389 
alters a highly-conserved domain in the protein, the conserved amino acid that varies is 390 
underscored. 391 
  392 
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Odorant 
receptor name 
Frequency of 
pseudogene allele 
Result Agonist 
OR2B11 43% 8 amino acid protein Cinnamaldehyde 
OR4E2 30% MAYDRY domain Amyl acetate 
OR8K3 24% MAYDRY domain (+)-Menthol 
OR10A6 22% PMLNPLIY domain 3-phenyl propyl propionate 
OR2C1 4% 272 amino acid protein Octanethiol 
OR4Q3 1.50% 159 amino acid protein Eugenol 
OR10G7 1.40% 191 amino acid protein Eugenol 
Table 1 393 
  394 
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METHODS 395 
Cloning 396 
Odorant receptor open reading frames were amplified from the genomic DNA of 20 397 
participants from the International Hapmap Consortium using Phusion polymerase and 398 
subcloned into pCI expression vectors (Promega) containing the first 20 residues of 399 
human rhodopsin (Rho tag). The sequences of the cloned receptors were verified by 400 
sequencing (3100 Genetic Analyzer, Applied Biosystems).  401 
Fluorescence-activated Cell Sorter (FACS) Analysis 402 
We conducted FACS analysis on all tested clones for the 17 odorant receptors where we 403 
had more than one clone (Supplementary Fig. 5).  Hana3A cells were maintained in 404 
minimal essetial medium (Sigma) containing 10% fetal bovine serum (Sigma), 500 ug/ml 405 
peniciilin-streptomycin (Invitrogen) and 6 ug/ml amphotericin B (Sigma). Cells were 406 
seeded in 35mm dishes (Falcon) and grown overnight at 37C and 5% CO2.  The 407 
following day, each dish was transfected using 4ul Lipofectamine 2000 (Invitrogen), 408 
1200ng Rho-tagged odorant receptor, 300ng hRTP1S, and 20ng of EGFP to control for 409 
transfection efficiency. 24-hours post-transfection, cells were washed with PBS and 410 
detached from the dishes using Cellstripper (Cellgro). Primary incubation was carried out 411 
at 4C using mouse monoclonal antibody anti-rhodopsin 4D231 (gift from R. Molday) 412 
diluted 1:50 in PBS containing 2% FBS, and 15mM NaN3 for 30 minutes. Cells were 413 
washed in PBS/FBS/NaN3, followed by secondary incubation with Phycoerythrin (PE)-414 
conjugated donkey anti-mouse antibody (Jackson Immunologicals) diluted 1:100 in 415 
PBS/FBS/NaN3 for 30 minutes covered with aluminum foil. Cells were washed and 416 
resuspended in PBS/FBS/NaN3 containing 1:500 dilution of 7-Aminoactinomycin D 417 
(7AAD 1mg/ml; Calbiochem), a fluorescent, cell-impermeable DNA binding agent that 418 
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selectively stains dead cells.  Fluorescent cell sorting was conducted using a BD 419 
FACSCanto (BD Biosciences). Cells that were EGFP-negative and/or 7AAD-positive 420 
were removed from further analysis.  Cell-surface expression is quantified as PE 421 
fluorescence intensity. Data collection and analysis were not randomized. 422 
Luciferase assay 423 
The Dual-Glo™ Luciferase Assay System (Promega) was used to measure receptor 424 
reponses as previously described20. Hana3A cells were transfected with 5 ng/well of 425 
RTP1S32, 5 ng/well of pRL-SV40, 10 ng/well of CRE-luciferase, 2.5 ng/well of M333, and 426 
5 ng/well of odorant receptor. 1M odorant stocks are diluted in DMSO.  24 hours 427 
following transfection, transfection media was removed and replaced with the 428 
appropriate concentration of odor diluted from the 1M stocks in CD293 (Gibco). Four 429 
hours following odor stimulation luminescence was measured using a Polarstar Optima 430 
plate reader (BMG). All luminescence values were divided by the Renilla Luciferase 431 
activity to control for transfection efficiency in a given well. Data were analyzed with 432 
Microsoft Excel, GraphPad Prism 4, and MATLAB. 433 
1000 Genomes Project data 434 
Allele frequency in the human population was derived from the May 2011 phased 435 
release of the 1000 Genomes Project public data (ftp://ftp-436 
trace.ncbi.nih.gov/1000genomes/ftp/release/20110521/)22. Variant calls were obtained 437 
from the public repository in vcf format using tabix34.  A custom-written MATLAB script 438 
was used to translate the vcf file into 2184 full-length phased alleles (two alleles for each 439 
of the 1092 participants in the public database). 440 
  21 
Human odorant receptor genotyping 441 
Venous blood (8.5 ml) was collected from participants and genomic DNA was 442 
prepared with the Qiagen PAXgene blood DNA kit.  For sequencing, human genomic 443 
DNAs were amplified with HotStar Taq (Qiagen) with primers upstream (5’- 444 
ACCTGGTTGATGCAGTTTCC-3’) and downstream (5’- 445 
AAACCTATTGATGAGAAATGAGTCAA-3’) of the OR10G4 open reading frame. The 446 
PCR products were then purified using Sephacryl S-400 (GE Healthcare) and 447 
sequenced with a 3100 or 3730 Genetic Analyzer (ABI Biosystems).  448 
Procedures for olfactory psychophysics 449 
All psychophysical data was obtained from Keller et al. (2012)19 and approved by the 450 
Rockefeller University Institutional Review Board. All subjects gave informed consent to 451 
participate and were financially compensated for their time and effort. Exclusion criteria 452 
for subjects were: allergies to odors or fragrances, a history of nasal illness, upper 453 
respiratory infection, seasonal allergy, prior endoscopic surgery on the nose, pre-existing 454 
medical condition that has caused a reduced sense of smell such as head injury, cancer 455 
therapy, radiation to head and neck, or alcoholism. Pregnant women and children under 456 
18 were excluded from this study.  Of the 308 subjects (138 male), 133 were Caucasian, 457 
29 were Asian, and 77 were African-American.  The median age was 35 years, with a 458 
range of 19 to 66.  In brief, participants rated the intensity and valence of 66 odorants on 459 
a 7-point scale. The intensity scale was labeled with 1 as “extremely weak” and 7 as 460 
“extremely strong”.  The valence scale was labeled with 1 as “extremely unpleasant” and 461 
7 as “extremely pleasant”.  Stimuli were presented in jars.  For a detailed description of 462 
the psychophysical methods, see Keller et al.9. Three of these odorants, ethyl vanillin, 463 
vanillin and guaiacol, are in vitro agonists to OR10G4.  We examined the ratings of the 464 
higher of two tested concentrations.  Ethyl vanillin and vanillin were presented at a 1/200 465 
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dilution in propylene glycol, guaiacol was presented at a 1/1,000,000 dilution in paraffin 466 
oil.  Our data collection and analysis was blind to genotype, as all sequencing was 467 
conducted after phenotyping of the human subjects was complete.  Data collection and 468 
analysis were not randomized. 469 
Statistical analysis 470 
Screening procedure 471 
We stimulated the entire odorant receptor library with 73 odorants used in previous 472 
psychophysical testing9. We applied the odorants at 100 µM (except for androstenone 473 
and androstadienone, which were both applied at 10 µM) and ranked odorant/receptor 474 
pairs by their activity above the no odor condition. We selected the top 5% of 475 
odorant/receptor pairs from this primary screen--some receptors were very promiscuous, 476 
so we tested only the top ten ligands for a given receptor.  We then performed a 477 
secondary screen in which each odorant receptor was tested against a no-odor control 478 
as well as 1, 10 and 100 µM. Each comparison was performed in triplicate, where each 479 
measure was collected from separate wells, but each well contains cells from the same 480 
parent plate of cells. Statistical significance was assessed by 2-sided t-test comparing 481 
the 3 wells stimulated with odor with the 3 wells stimulated with media alone. As this was 482 
a screening procedure, the data distribution was assumed to be normal but this was not 483 
formally tested.  In addition, the tests were uncorrected for multiple comparisons. We 484 
then constructed dose-response curves using concentrations ranging from 10 nM to 10 485 
mM for the odor/receptor pairs that were significantly different from baseline in the 486 
secondary screen. Each odorant receptor-odorant dose was tested in triplicate, where 487 
each measure was collected from separate wells, but each well contains cells from the 488 
same parent plate of cells, and a vector-only control was included for each odorant. We 489 
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fit the data to a sigmoidal curve. We counted an odorant as an agonist if the 95% 490 
confidence intervals of the top and bottom parameters did not overlap, the standard 491 
deviation of the fitted log EC50 was less than 1 log unit, and the extra sums-of-squares 492 
test confirmed that the odorant activated the receptor significantly more than the control, 493 
which was transfected with an empty vector. Data collection and analysis were not 494 
randomized. 495 
Screening 55 odorants 496 
To choose 55 odorants that quantitatively span chemical space we generated 20 497 
physicochemical descriptors that predict 62% of the variance in mammalian odorant 498 
receptor responses17 for 2715 commonly used odorants. We then divided the 2715 499 
odorants into 55 clusters using k-means clustering. For each cluster, we selected the 500 
odorant closest to the centroid of the cluster among odorants that are previously shown 501 
to activate at least one odorant receptor. If no such agonist was present in the cluster, 502 
we selected the odorant closest to the centroid of the cluster to maximize structural 503 
diversity. Each odorant was screened against each receptor variant at 100 µM in 504 
triplicate where each measure was collected from separate wells, but each well contains 505 
cells from the same parent plate of cells.  We performed an ANOVA on the responses 506 
from the clones of each odorant receptor. We used 15 odorant receptors where we had 507 
more than one allele cloned with an allele frequency greater than 1% in the 1092 508 
participants and the cloned alleles represented a large percentage of the 2184 alleles. 509 
For 13 odorant receptors, the cloned alleles represented more than 85% of the 2184 510 
alleles. For OR2B11 the cloned alleles represented 37.5% of the alleles and for OR10G4 511 
the cloned alleles represented 29.5% of the alleles. Data collection and analysis were 512 
not randomized. 513 
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Dose response curves 514 
We tested odorant receptors with odorants ranging in concentration from 10 nM to 10 515 
mM. All numerical results are reported as mean ± s.e.m. and represent data from a 516 
minimum of three replicates, where each measure was collected from separate wells, 517 
but each well contains cells from the same parent plate of cells.  We fit the resulting data 518 
with a 3-parameter logistic model. We counted an odorant as an agonist if the 95% 519 
confidence intervals of the top and bottom parameters did not overlap, the standard 520 
deviation of the fitted log EC50 was less than 1 log unit, and the extra sums-of-squares 521 
test confirmed that the odorant activated the receptor significantly more than the vector-522 
only transfected control. 523 
For each pair of alleles, we determined if one model fit the data from both alleles 524 
better than two separate models using the extra sums-of-squares test. A pair of alleles 525 
was classified as hyper/hypofunctional if one allele in the pair had both a higher EC50 526 
(lower efficacy) and a lower potency (dynamic range, or top-bottom). A pair of alleles 527 
was designated as “unclassified” if the potency and efficacy showed discordant changes 528 
(i.e. one allele was more sensitive, but had a lower efficacy). 529 
To compare each pair of individuals, we took the four alleles from a single odorant 530 
receptor and removed any pairs of alleles that were indistinguishable according to the 531 
above criteria. Each remaining pair was counted as one functional difference. These 532 
values were summed across odorant receptors, with a maximum of 48 possible 533 
functional differences per pair of participants. Data collection and analysis were not 534 
randomized. 535 
Odds that a SNP alters function 536 
We aligned the nucleotide sequences of the odorant receptor variants to a multiple 537 
sequence alignment of 1425 intact mouse and human odorant receptors. For each SNP 538 
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we calculated the ratio of the odds that a functional change (as defined above, relative to 539 
the most common functional variant) occurred in an allele with a non-synonymous amino 540 
acid to the odds that a functional change occurred in an allele with a synonymous amino 541 
acid.  We used SNPnexus35 (Ensembl 63 build) to generate GERP, SIFT, and Polyphen 542 
scores. 543 
Multiple linear regression model 544 
Multiple regression analysis was used to test if the number of OR10G4 alleles 545 
significantly predicted participants’ perception of the three in vitro agonists.  To 546 
determine the minimum sample size for this analysis, we performed a Monte-Carlo 547 
simulation using the data from Keller et al.9.  We ranked each subject’s ratings of the 548 
odorants to control for differences in general olfactory acuity and usage for the rating 549 
scale across subjects.  The predictors were allele counts (0,1,or 2) for the four alleles 550 
with MAF > 4% in the participant population. Data collection and analysis were not 551 
randomized. 552 
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